Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precision Smoking Cessation Therapy Study
ChiCTR2000041343Phase 4Recruiting
- Sponsor
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of varenicline, bupropion and nicotine in nicotine dependence (4 arms), sponsored by Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital. Primary endpoint: Continuous smoking cessation rate at weeks 9–12 verified by exhaled carbon monoxide. Started Jan 2021; status: recruiting.
02
Drugs
vareniclinebupropionnicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on ChiCTR2000041343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041343.